Cutaneous Candidiasis

• FDA approval · 2016-01-07
  FDA Approved: NYSTATIN — Original Application (Pharmaceutical Associates, Inc.)

  FDA approved a generic Nystatin product from Pharmaceutical Associates, Inc. under an original application (ANDA).

• FDA approval · 2015-10-30
  FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc. USA)

  FDA approved Glenmark's generic topical combination of clotrimazole and betamethasone dipropionate (ANDA 202894). It is indicated for inflam…

• FDA approval · 2015-09-11
  FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

  FDA approves a supplemental application for clotrimazole and betamethasone dipropionate (topical antifungal with corticosteroid) from E. Fou…

• FDA approval · 2015-03-03
  FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals. The update modifies the labe…

• FDA approval · 2014-12-01
  FDA Approved: CICLOPIROX — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved a supplemental application for Ciclopirox from Glenmark Pharmaceuticals Inc., USA.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2013-01-03
  FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)

  FDA approves a supplemental application for ketoconazole submitted by Thirty Madison Inc (ANDA076942).

• FDA approval · 2011-02-23
  FDA Approved: CICLOPIROX — Original Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved Sun Pharmaceutical's Ciclopirox as an original ANDA, authorizing the generic topical antifungal product.

• FDA approval · 2010-02-16
  FDA Approved: CICLOPIROX — Original Application (Padagis Israel Pharmaceuticals Ltd)

  The FDA approved Padagis Israel Pharmaceuticals Ltd's Ciclopirox topical product under Original Application (ANDA 078594), authorizing its m…

• FDA approval · 2009-04-17
  FDA Approved: NYSTATIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved a supplemental application for NYSTATIN submitted by Padagis Israel Pharmaceuticals Ltd. The action confirms approval of the su…

• FDA approval · 2009-03-18
  FDA Approved: KETOCONAZOLE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

  FDA approved a supplemental ANDA for Ketoconazole, a generic antifungal product from E. Fougera & Co. (division of Fougera Pharmaceuticals).

• FDA approval · 2009-01-07
  FDA Approved: CICLOPIROX — Original Application (Padagis US LLC)

  FDA approved Padagis US LLC's original Abbreviated New Drug Application for ciclopirox, a topical antifungal.

• FDA approval · 2008-05-13
  FDA Approved: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for the topical antifungal and anti-inflammatory combination clotrimazole and betamethasone dipropio…